Abstract
1292
Objectives Although multiple components of serotonin (5-HT) systems have been implicated in alcohol dependence (AD), the 5-HT1B receptor (5-HT1BR) receives particularly strong support. We studied 5-HT1BR binding potential (BPND) in 4 medication-free, recently abstinent (at least 4 weeks) patients with AD (1 female, age 33.5±10.2) compared to 5 matched healthy control subjects (HC) (1 female, age 32.4±8.7).
Methods [11C]P943, a selective 5-HT1BR antagonist tracer was synthesized using GE's FXC module and/or Bioscan's AutoLoop by methylation with C-11 methyl triflate or C-11 methyl iodide, respectively. Following a transmission scan, [11C]P943 was injected by pump over one min. and HRRT list mode data were acquired for 120 min. Imaging data were analyzed using a multilinear reference tissue model (MRTM2).
Results We found reductions in limbic-cortical 5-HT1B receptor BPND values in AD versus HC and elevated ventral striatal 5-HT1B receptor BPND values (2.21±.57 versus 1.57±.32, p=.03) in AD versus HC. No influence of age, sex, BMI or amount of injected radiotracer was observed.
Conclusions The current data provide the first direct evidence that 5-HT1B receptors are implicated in AD. The group differences in ligand binding are limited to circuits that were previously implicated in AD by human functional neuroimaging studies. Increased expression of ventral striatal 5-HT1B receptors has been linked to AD in preclinical studies, a model that is supported by our pilot data.
Research Support This study was supported in part by grant RAA017540A.
- © 2009 by Society of Nuclear Medicine